Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven
Condition: Acute Myeloid Leukemia Interventions: Other: Pharmacokinetic sampling; Other: Vital status determination; Other: Toxicity assessments; Drug: Venetoclax and azacitidine combination Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials